UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2873) 2873
Newsletter (13) 13
Book Chapter (7) 7
Magazine Article (6) 6
Conference Proceeding (4) 4
Newspaper Article (3) 3
Book / eBook (1) 1
Book Review (1) 1
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2276) 2276
amlodipine - therapeutic use (1861) 1861
science & technology (1855) 1855
life sciences & biomedicine (1822) 1822
male (1664) 1664
hypertension - drug therapy (1582) 1582
female (1495) 1495
middle aged (1372) 1372
amlodipine (1251) 1251
antihypertensive agents - therapeutic use (1185) 1185
aged (1055) 1055
calcium channel blockers - therapeutic use (983) 983
hypertension (975) 975
blood pressure - drug effects (895) 895
adult (820) 820
cardiovascular system & cardiology (800) 800
biological and medical sciences (741) 741
medical sciences (732) 732
treatment outcome (665) 665
pharmacology & pharmacy (634) 634
drug therapy, combination (593) 593
amlodipine - administration & dosage (570) 570
hypertension - physiopathology (555) 555
amlodipine - adverse effects (538) 538
pharmacology. drug treatments (535) 535
double-blind method (513) 513
peripheral vascular disease (494) 494
amlodipine - pharmacology (439) 439
cardiovascular system (407) 407
antihypertensive agents - administration & dosage (383) 383
blood pressure (361) 361
tetrazoles - therapeutic use (356) 356
cardiac & cardiovascular systems (347) 347
antihypertensive agents - adverse effects (343) 343
animals (341) 341
hypertension - complications (340) 340
drug combinations (335) 335
antihypertensive agents (333) 333
drug therapy (320) 320
angiotensin-converting enzyme inhibitors - therapeutic use (281) 281
calcium channel blockers - adverse effects (274) 274
prospective studies (270) 270
abridged index medicus (267) 267
calcium channel blockers - pharmacology (256) 256
calcium channel blockers - administration & dosage (255) 255
valsartan (238) 238
risk factors (235) 235
time factors (233) 233
cardiology. vascular system (231) 231
general & internal medicine (215) 215
medicine, general & internal (211) 211
antihypertensive agents - pharmacology (210) 210
hydrochlorothiazide - therapeutic use (208) 208
angiotensin ii type 1 receptor blockers - therapeutic use (205) 205
blood and lymphatic vessels (199) 199
dosage and administration (194) 194
dose-response relationship, drug (188) 188
calcium channel blockers (184) 184
aged, 80 and over (183) 183
arterial hypertension. arterial hypotension (183) 183
valine - analogs & derivatives (182) 182
heart rate - drug effects (174) 174
research (174) 174
medicine & public health (169) 169
blood pressure monitoring, ambulatory (161) 161
nifedipine - therapeutic use (161) 161
rats (159) 159
tetrazoles - administration & dosage (155) 155
care and treatment (153) 153
follow-up studies (151) 151
internal medicine (149) 149
valine - therapeutic use (149) 149
randomized controlled trials as topic (148) 148
adolescent (147) 147
calcium channel blocker (140) 140
analysis (139) 139
clinical trials (134) 134
benzimidazoles - therapeutic use (133) 133
cross-over studies (132) 132
tetrazoles - adverse effects (132) 132
diuretics (131) 131
hypertension - blood (130) 130
cardiology (129) 129
diuretics - therapeutic use (126) 126
pharmacology/toxicology (124) 124
blood pressure - physiology (122) 122
antihypertensive drugs (119) 119
amlodipine - pharmacokinetics (116) 116
hydrochlorothiazide - administration & dosage (114) 114
cardiovascular disease (113) 113
health aspects (110) 110
losartan - therapeutic use (109) 109
cardiovascular diseases - prevention & control (108) 108
enalapril - therapeutic use (108) 108
hydrochlorothiazide (108) 108
lisinopril - therapeutic use (108) 108
medicine, research & experimental (107) 107
research & experimental medicine (106) 106
angina pectoris - drug therapy (105) 105
clinical trials as topic (103) 103
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2735) 2735
Russian (68) 68
German (57) 57
Japanese (36) 36
Spanish (19) 19
French (18) 18
Chinese (17) 17
Italian (12) 12
Hungarian (10) 10
Polish (8) 8
Portuguese (7) 7
Ukrainian (6) 6
Czech (3) 3
Norwegian (3) 3
Danish (2) 2
Dutch (2) 2
Swedish (2) 2
Bosnian (1) 1
Croatian (1) 1
Hebrew (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 0028-4793, 08/2008, Volume 359, Issue 7, pp. 677 - 687
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 1, pp. 13 - 22
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | General aspects | Renovascular diseases | Atherosclerosis (general aspects, experimental research) | Nephropathies. Renovascular diseases. Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Blood and lymphatic vessels | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Renal Insufficiency, Chronic - complications | Renal Artery | Treatment Failure | Cardiovascular Diseases - mortality | Female | Angioplasty, Balloon | Pyrroles - therapeutic use | Stents | Cardiovascular Diseases - etiology | Renal Artery Obstruction - drug therapy | Kaplan-Meier Estimate | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Renal Artery Obstruction - complications | Anticholesteremic Agents - therapeutic use | Hypertension - complications | Aged | Renal Artery Obstruction - therapy | Drug Combinations | Prevention | Evaluation | Care and treatment | Usage | Atherosclerosis | Therapeutics | Stent (Surgery) | Homeopathy | Materia medica and therapeutics | Hypertension | Myocardial infarction | Cerebral infarction | Stroke | Kidneys | Renal artery | Antihypertensives | Medical treatment | Clinical trials | Stenosis | Cardiovascular disease | Congestive heart failure | Renal insufficiency | Arteriosclerosis | Implants | Renal failure | Blood pressure | Kidney diseases | Geriatrics | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 12/2008, Volume 359, Issue 23, pp. 2417 - 2428
Journal Article
The Lancet (British edition), ISSN 0140-6736, 06/2004, Volume 363, Issue 9426, pp. 2022 - 2031
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcium Channel Blockers - adverse effects | Valsartan | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - therapeutic use | Angiotensin II Type 1 Receptor Blockers | Endpoint Determination | Diuretics | Female | Blood Pressure - drug effects | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Hydrochlorothiazide - therapeutic use | Hypertension | Medical research | Side effects | Drug therapy | Drugs | Heart attacks | Heart surgery | Angioplasty | Antihypertensives | Risk | Cardiovascular disease | Evidence-based medicine | Blood | Randomization | Measurement techniques | Blood pressure | Heart diseases | Age | Heart failure | Edema | Stroke | Mortality | Medical treatment | Health risks | Angina pectoris | Patients | Coronary artery disease | Morbidity | Hypotheses | Coronary vessels | Diabetes | Cardiovascular diseases | Health risk assessment | Mercury | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
BMC nephrology, ISSN 1471-2369, 01/2019, Volume 20, Issue 1, pp. 1 - 1
Metastatic renal cell carcinoma | Nephrotic syndrome | Pazopanib | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Lung Neoplasms - drug therapy | Humans | Carcinoma, Renal Cell - surgery | Hypertension - drug therapy | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Pancreaticoduodenectomy | Pneumonectomy | Protein Kinase Inhibitors - adverse effects | Dihydropyridines - adverse effects | Pancreatic Neoplasms - drug therapy | Angiogenesis Inhibitors - administration & dosage | Pancreatic Neoplasms - secondary | Lung Neoplasms - secondary | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Everolimus - therapeutic use | Carcinoma, Renal Cell - drug therapy | Nephrotic Syndrome - chemically induced | Angiogenesis Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Pyrimidines - administration & dosage | Pancreatic Neoplasms - surgery | Nivolumab - therapeutic use | Combined Modality Therapy | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Diabetic Nephropathies - complications | Dihydropyridines - therapeutic use | Edema - etiology | Protein Kinase Inhibitors - administration & dosage | Sulfonamides - therapeutic use | Sunitinib - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Kidney Failure, Chronic - complications | Pyrimidines - adverse effects | Hypertension - complications | Sulfonamides - adverse effects | Lung Neoplasms - surgery | Aged | Drug Substitution | Sulfonamides - administration & dosage | Antimitotic agents | Care and treatment | Albumin | B cells | Carcinoma, Renal cell | Metastasis | Antineoplastic agents | Health aspects | Cancer | Urine | Hypertension | Edema | Biomedical research | Family medical history | Patients | Cholesterol | Metastases | Proteins | Biopsy | Renal cell carcinoma | Kidney cancer | Antitumor activity | Blood pressure | Clinical medicine | Vascular endothelial growth factor | Drug dosages | Research centers | Index Medicus
Journal Article